Halt™ Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)
Halt™ Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)
Citations & References (5)
Thermo Scientific™

Halt™ Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)

Thermo Scientific Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)は詳細を見る
テクニカルサポートオーダーサポート
表示を変更buttonViewtableView
製品番号（カタログ番号）数量
784411 mL
7844324 x 100 μL
784455 x 1 mL
7844710 mL
製品番号（カタログ番号） 78441
価格（JPY）
68,800
Each
お問い合わせください ›
数量:
1 mL
一括またはカスタム形式をリクエストする
Thermo Scientific Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)は、1つの溶液で細胞および組織ライセートのタンパク質サンプルを完全に保護します。

Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X)の特長：

•完全な保護—オールインワンカクテルはプロテアーゼとホスファターゼの両阻害剤を含有
• 複数のパッケージサイズ—4つの便利なパッケージサイズから選択できるため、ほぼすべての実験規模に適合
• 便利—100倍濃縮組成は、個別の阻害剤やその他のフォ＝マットよりも使いやすく効果的
• 保存が容易—水性フォーマットはDMSOベースのカクテルとは異なり冷凍する必要がなく、低温室で保存可能
• 適合性—ピークシフトを引き起こす可能性のあるAEBSFを含んでいないため、質量分析（MS）に使用可能
• 検証済み—Thermo Scientific Pierce Cell Lysis Bufferに完全に適合に完全に適合

Halt Protease and Phosphatase Inhibitor Cocktailは、タンパク質の抽出や精製中にタンパク質が分解されるのを防ぐよう、特別に最適化されています。カクテルには、アミノペプチダーゼ、システインおよびセリンプロテアーゼ、セリン／スレオニンおよびタンパク質チロシンホスファターゼを標的とする主要分類のプロテアーゼおよびホスファターゼに対する阻害剤が含まれます。

関連製品
Halt™ Protease and Phosphatase Inhibitor Cocktail (100X)
研究用途にのみご使用ください。診断目的には使用できません。
仕様
バッファーLysis Buffer
概要Halt Protease and Phosphatase Inhibitor Cocktail, EDTA-Free
阻害剤プロテアーゼ阻害剤、ホスファターゼ阻害剤
数量1 mL
試薬タイププロテアーゼ阻害剤、ホスファターゼ阻害剤
形状液体
製品ラインHalt
製品タイプProtease and Phosphatase Inhibitor Cocktail
Unit SizeEach
組成および保存条件
受け取り後4℃で保存。製品はアイスパック入りで出荷されます。製品を冷凍しないでください。

よくあるご質問（FAQ）

Can I store the 1X solution of the Halt Protease and Phosphatase Inhbitor Cocktail and if so, for how long?

The stability of the 1X solution is undetermined. For best results, prepare solutions just before use. The 100X concentrate is stable for at least one year stored at 4 degrees C.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

What are the concentrations of the various components of the combined Halt Protease and Phosphatase Inhibitor Cocktail?

Although we reveal the identity of the inhibitors in the combined cocktail, their concentrations are proprietary.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

Do you offer the components of the Halt Protease and Phosphatase Cocktail individually?

Yes. Halt Protease, Halt Phosphatase and Protease/Phosphatase combined Inhibitor Cocktails are available. In addition, some of the individual inhibitors of the Halt Protease and Phosphatase Inhibitor Cocktail are offered separately.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

When do I need to add EDTA when using the Halt Protease and Phosphatase Cocktail?

EDTA chelates the metal ions required for metalloprotease activity. Add EDTA if metalloproteases are likely to adversely affect target protein function; however, avoid using EDTA when the downstream application involves metal chelate affinity purification or the target protein requires metals for proper function.

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

How much of the Halt Protease and Phosphatase Cocktail do I use for my sample?

The Halt Protease and Phosphatase Cocktail is supplied at a 100X concentrate and is used at 1X. For example, add 10µL of 100X Halt Cocktail to 1mL of sample. Some samples, however, contain high levels of proteases or phosphatase and might require a more concentrated treatment (i.e., 2-3X).

Find additional tips, troubleshooting help, and resources within our Protein Purification and Isolation Support Center.

View all Halt™ Protease and Phosphatase Inhibitor Cocktail, EDTA-free (100X), 1 mL FAQs

引用および参考文献 (5)

引用および参考文献
Abstract
Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α.
Authors:Lowery CD,Blosser W,Dowless M,Knoche S,Stephens J,Li H,Surguladze D,Loizos N,Luffer-Atlas D,Oakley GJ 3rd,Guo Q,Iyer S,Rubin BP,Stancato L
Journal:Clinical cancer research : an official journal of the American Association for Cancer Research
PubMed ID:29191969
Purpose: Platelet-derived growth factor receptor α (PDGFRα) is implicated in several adult and pediatric malignancies, where activated signaling in tumor cells and/or cells within the microenvironment drive tumorigenesis and disease progression. Olaratumab (LY3012207/IMC-3G3) is a human mAb that exclusively binds to PDGFRα and recently received accelerated FDA approval and conditional ... More
Reverse phase protein microarray technology in traumatic brain injury.
Authors:Gyorgy AB,Walker J,Wingo D,Eidelman O,Pollard HB,Molnar A,Agoston DV
Journal:Journal of neuroscience methods
PubMed ID:20674607
Antibody based, high throughput proteomics technology represents an exciting new approach in understanding the pathobiologies of complex disorders such as cancer, stroke and traumatic brain injury. Reverse phase protein microarray (RPPA) can complement the classical methods based on mass spectrometry as a high throughput validation and quantification method. RPPA technology ... More
Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis.
Authors:Liu MC,Logan H,Newman JJ
Journal:Molecular biology reports
PubMed ID:33021719
The role of the Notch signaling pathway in adipogenesis has long been controversial as the action of individual Notch receptors appears to vary with experimental conditions. In this study, we offer some explanation for the observed contradictions by comparing the role of both Notch1 and Notch3 in regulating the expression ... More
Quantitative PCR analysis of DNA, RNAs, and proteins in the same single cell.
Authors:Ståhlberg A, Thomsen C, Ruff D, Åman P
Journal:Clin Chem
PubMed ID:23014600
The single cell represents the basic unit of all organisms. Most investigations have been performed on large cell populations, but understanding cell dynamics and heterogeneity requires single-cell analysis. Current methods for single-cell analysis generally can detect only one class of analytes. ... More
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
Authors:Id Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F
Journal:BMC Cancer
PubMed ID:20565769
The proto-oncogene Src is an important non-receptor protein tyrosine kinase involved in signaling pathways that control cell adhesion, growth, migration and differentiation. It negatively regulates osteoblast activity, and, as such, its inhibition is a potential means to prevent bone loss. Dasatinib is a new dual Src/Bcr-Abl tyrosine kinase inhibitor initially ... More